Esmolol vs. Labetalol in Endoscopic Sinus Surgery

Completed · Phase 2

Conditions studied: Chronic Sinusitis

In brief

The purpose of this study is to compare esmolol and labetalol bleeding and intra-operative visibility scores in functional endoscopic sinus surgery.

Key facts

Study ID

NCT03661346

Run by

The University of Texas Medical Branch, Galveston

People needed

28

Starts

2017-03-01

Expected to finish

2018-03-30

Last updated by the study team

2021-02-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of CRS with or without nasal polyps
• Undergoing FESS for CRS
• American Society of Anesthesiologists (ASA) physical status 1 (healthy) or 2 (patient with mild systemic disease).

You may not qualify if…

• Pregnancy
• Asthma
• COPD
• Bradycardia
• Heart failure
• End stage renal disease
• Cerebrovascular accident
• Diabetes mellitus
• Preoperative use of NSAIDs, aspirin, or beta-blockers
• Body mass index (BMI) greater than 40 kg/m2.

Where it is running

• University of Texas Medical Branch — Galveston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.